We conducted a prospective study to determine the incidence of middle ear barotrauma in patients who were undergoing hyperbaric oxygen therapy (HBOT) 
Introduction
Hyperbaric oxygen therapy (H BOT) has become both a prim ary and adjuva nt tre atment option for several diseases and clinic al entities . The goal of HBOT is to in crease tissue oxygen atio n levels to no rm al or even supranormal in order to promot e wound healing and leukocyte bacte ricid al activity.' However, increasing th e part ial oxygen pressure in tissue and the atm ospheric pres sure during the rap y m ay result in complications, th e most common of which appears to be middle ear barotrauma.' Barotrauma can m ani fest as pain and pr essur e in the ear,sero us otitis media, hemotympan um, and tympanic membra ne perforations.t" Although most of th ese complications are m inor and temporary,they may force clinicians to pause or cease ongoing th erapy.
We know that patients with artificial airways and patients who are unconsciou s are at risk for barotraum a and its complications followin g HBOT, but th ere is still a necessity to identify new risk gro ups in order to lower complication rates. 5 • 8 • 9 Studi es of bar ot rau ma risk have focused on eustachian tube funct ion and th e use of pr ophylactic autoins ufflation. For exam ple, in a study of 90 patients, Miyazawa et al found th at poor eustachia n tu be functio n prior to the ad m inistratio n of either hypo-or hyp erb aric oxygen was assoc iated with a higher incidence of post -t reat m ent barotrauma.'? Fernau et aF cond ucted a sim ilar study in 33 adults usin g the nine-step inflati on/deflati on test" and found th at patients who entered th e study with norm al eustachian tube function and manifested poo r eustachian tube function after th e first HBOT session had a significantly higher incidence of barotrauma. Finally, Beuerlein et al compared two gro up s of HBO T patients-those who
• There is 110 grade2 ;11 this modification. Regardless of eustachia n tube function, all patients then underwent HBOT according to a routine diving protocol. Each patient received brief instruction regarding the procedure,its possible complications,and preventive auto insufflation techniques.Therapy was administered at 2.5 ATA (absolute atmospheres) in a monoplace ( l -person) hyperbaric oxygen chamber for 90 minutes a day. Although the duration ofHBOT was planned for at least 7 days, we left open the option to curtail therapy if complications necessitated cessation.
Within 1 ho ur after the comp letion of their first HBOT session, patients again underwent the nine-step inflation/deflation test and an otoscopic examination. Thereafter, patients underwent an oto scopic examination alone by one of the authors (H.A.) in the Department of Unde rsea and Hyperbaric Medicine prior to every HBOT session . Patients were requested to return to the Department of OHNS at the end of the 7 days for a final otoscopic evaluation; they were asked to return earlier if th ey experienced any discomfort or pain .
Otoscopic findings were categori zed according to the modified Teed classification system of middle ear barotrauma (table). The original Teed classification system " was introduced in 1944, and since then it has been mod ified several times to clarify som e confusion in defining the nature of effusion ;we used the modificat ion pub lished by Beuerlein et al s in 1997.
Allstatistical analyses were performed with the Statisti- Step 2: The ear canal pressure is increased to +400 mm Hp, and the patient is asked to swallow three times to equalize the overpressure via the eustachian tube.
-Step 3: The second tympanogram is obtained. o Step 4: After the audiologist normalizes the ear canal pressure, the patient swallows three times to overcome the negative intratympanic pressure that was provoked during the first three steps.
were able to auto insufflate the middle ear (n = 19) and th ose who were not (n = 11); otoscopic exami nation revealed that th e incidence and severity of barotrau ma were significantly lower in the patients who were able to equalize their middle ear pressure with that of the outside atmosphere. ' We conducted a prospective study to determine the incidence of middle ear barotrauma in agroup of patients undergoing HBOT.Wealso investigated the value of the nine-step inflation/deflation test and otoscopic findings before and immediatelyafter the initia l HBOT session in predicting barotra uma in an attempt to establish some criteria for prophylaxis.
Patients and methods
We invited into our study all patients who had been undergoing HBOT at the Culhane Military Medical Academy's Hyperbaric Oxygen Therapy Center from February through September 2005. To be eligible, patients had to have been at least 18 years old and not unconscious, and theymust have had no art ificial airway and no history of eustac hian tu be dysfunction.
Eighteen patients (36 ears) volunteered for the study-12 men (mean age:47.3 ± 11.8yr) and 6 women (mean age: 48.0 ± 13.4). These patients were scheduled to undergo a minimum of 7 days of HBOT for one of three indications: sudden hearing loss (n = 10), wound healing complications (n = 5), or diabetic complications (n =3). All the patients were without middle ear prob lems at the beginn ing of the study. All patie nts un derwent an oto logic examina tion in the Department of Otorhinolaryngolog y-Head and Neck Surgery (OHNS) by one of the authors (S.K. or Y.F.Y.). Thi s examination was followed by the nine-step inflation/deflation test designed by Bluestone ." The methodology of this test has been described in several articl es.o!':" Briefly, it involves consecutive measurements of intratympanic pressure : ) ; the differenc e between these 2 groups was not statistically significant (p = 0.095). The sensitivity and specificity of the pretreatment nine-step inflation/deflation test in pr edicting barotrauma during the first 7 days of HBOT were 61 and 66%, respectively. Within 1 hou r after the first HBOT session, the nin e-step test revealed that eustachian tube function was normal in 10 of the 36 ears (27.8%) and poor in the other 26 (72.2% ). Barotrauma developed in 5 of the 10 normal ears (50.0%) and in 13 of the 26 poor ears (50.0% ); again, the difference was not stat istically significant (p = 0.099). The sensitivity and specificity of the nine -step test perform ed immediately after the first HBOT session in pr edicting barotrauma during the first 7 days of HBOT were 72 and 27%, respectively.
Of the 19 ears with normal eustachian tube function at baseline, a deterioration in function was seen in 9 (47.4%) immediately following th e first HBOT session. Of the 17 ears with poor pretreatment eustachian tube function, none showed any improvement in function after the first session. The difference between the 2 groups was statistically significant (p =0.04).
Of the 9 previously normal ears in which eustachian tube funct ion deteriorated after the first HBOT session, barotrauma developed in 2 (22.2%). Of the 10 normal 686 · www.entjournal.com ears in which eustachian tube function remained normal after th e first HBOT session , barotrauma occurred in 5 (50.0%) . The difference was not statistically significant (p = 0.350), but the number of ears was sm all. Of the 17 ears with poor eustachian tub e function before and after the first therapy session , 6 (35.3%) underwent 7 days of treatment without barotrauma.
Otoscopicexamination. On otoscopic evaluation, 21
of the 36 ears (58.3%) were normal following the first session of HBOT. Of these 21, 18 (85.7%) remained normal after 7 days of treatment, while baro trauma developed in the ot her 3 (14.3%); the difference was statistically significant (p < 0.001) . Moreover, all 18 ears that had not sustained barotrauma by day 7 of HBOT had been normal after the first session. The sensitivity and specificity of otoscopic exam ination performed immediately after the first therapy session in predicting barotrauma during 7 days ofHBOTwere 83 and 100%, respectively.
Discussion
Although HBOT is well kno wn as a primary tre atment for air embolism and decompression sickness, new investigations have prompted new indications in clinical practice settings. As a result , there has been an increase in not only the number of treated patients, but also the number of complications. When the pressure difference between the atmosphere and the middle ear reaches approximately 60 mm H 20, ear pain and pr essure may be experienced. If the pressure difference continues to increase, a transudate effusion begins to leak into the middle ear cavity. Such an effusion may become a hemorrhagic event if the vessel injuries participate in the pathologic proce ss. Perforation of the tympanic membrane may occur if equalization cannot be achieved.P:" If such should occur, autoinsufflation techniques such as the Valsalva and Toynb ee ma neuve rs and repeated swallowing are recommended to prevent barotraum a."
Prevention ofbarotrauma during air travel and divin g m ay be accomplished with oral pseudo ephedrine.P'" For patient s who cannot equalize pressure differences by autoinsufflation, myringotomy and ventilation tube insertion have been suggested as a preventive measure; unfortunately, these measures have complications of th eir own . 20 -23 And we know that patients with artificial airwaysand patients who are unconscious are candidates for prophylaxis.v'" but more evidence-based studies are needed to identify other at-risk gro ups in order to reduce complicatio n rates .
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Among the several complications ofHBOT that have been reported so far, middle ear barotrauma is the most common.' In a study of 67 patients, Igarashi et al found that the incidence of barotrauma was higher when assessments were based on otoscopic examination than on clinical symptoms (68.7 vs. 53.7%; p > 0.05). 4 In a prospective, double-blind study of the efficacy of the topica l nasal decongestant oxymetazoline in the prevention of barotrauma in 60 pat ients undergoing H BOT, Carlson et al found th at th e rates of ear discomfort in th eactive-treatm ent and placebo-cont rol groups were 63 and 67%, respectively (p = 0.99). 6 In a large retrospective study of 782 patients who had undergon e 11,376 HBOT sessions, Plafki et al found that more th an 17% of pat ients experienced ear pain or discom fort and 3.8% exhibited barotraumatic lesions on otoscopic examination.' The highest rate of barotrauma that we are aware of was 82%, reported by Ferna u et al.' In our study, 66.7% of patients exhibited barotrauma after 7 days of treatment.
When prophylactic myringotomy or ventilation tube insertion is being considered, we believe that th e risk of barotrauma for each ear must be evaluated separately. In our study, 6 patients had bilateral barotrauma and 6 others had unila tera l barotrauma; in all, barotrauma was seen in 18 of the 36 ears (50.0%).
The impact of eustachian tube function on th e development of barotr auma during HBOT has been repo rted in two studies:
• In the study by Fernau et al, which was publi shed in 1992, the authors attributed the high incidence of barotrauma to the selection of their study gro up .' They enrolled patients regard less of whether they had a subjective history of eustach ian tube dysfun ction, and they found that those who did have such a history had a higher incidence of barotrauma following HBOT. The fact that all 12 of the history-positive patie nts in that study developed barotrauma ensured a high overall complication rate. The authors concluded that a finding of poor eustachian tube function on the nine -step inflation/deflation test following the first HBOTsession was a significant risk factor for barotrauma.
• Four years later, Miyazawa et al reported the results of the ir prospective study of 100 ears in 50 patients who und erwent sono tubometry and tubotympanoaerodynamography," None of these pat ients had any symptoms or signs of midd le ear disease, irrespective of whether or no t they had a history of eusta chian tub e dysfun ction . The mean duration of HBOT was 16 days Volume 87, Number 12 (range: 9 to 24). Following a mean of 6 days (±3) of treatment, middle ear barotrauma was seen in 34 of the 100 ears (34.0%). Eustachian tube function was found to be impaired after the first treatment session for a period of2 hours.The authors concluded that abnormal pretreatment eustachian tube function was a predictor of m iddle ear barot rauma secondary to HBOT.
Even taking the results of these two studies into account, we were still reluctant to provide prop hylaxis to patien ts who were plannin g to undergo HBOT at our institution, especially to th ose who had no history of eustachian tub e dysfunction. Therefore, we decided to repeat the study by Ferna u et aF in a different group of patients in an attempt to confirm their findings. Knowing that all the patients in tha t study who had a subject ive history of eustach ian tube dysfunction developed barotrauma, we excluded such patients from our study.
In our study, the first session ofHBOT impaired eustachian tube funct ion significantly. However, the status of eustachian tube function as determined by the nine-step inflation/deflation test was not significantly related to the risk ofdeveloping barotrauma during the first 7 days of treatment. The ears that were considered to have had normal eustachian tube function prior to HBOT and poor function after the first session had a highe r risk of barotrauma than th e ears that had remai ned normal after the first treatment; however, the nu mbers of ears in th ese two groups were no t balan ced eno ugh to yield a stat istically significant result. Likewise, the sensitivity and specificity of pre-and post-treatment nine-step inflation/deflation tests in predicting baro trauma secondary to HBOT were unreliably low.
A significant and interesting finding of our study was the relationship between the otoscopic examination findings immediately after the initial HBOTsession and the incidence of barotrauma after 7 days of thera py. We observed that those ears that were not traumatized after the first treatment session were significantlylesslikely to be traumatized during the subsequent 6 days of therapy. Moreover, none of the ears with grade 1 barotrauma following the initial HBOT session were any better by the end of therapy; they either remained at grade 1 or they became worse.
Our study was limited by the fact that pure -tone audiometry, which is indisputably importan t for screening for and monitoring otologic complications, was not available to us. The reason is th at m ost of the patient evaluations took place in th e Depa rt ment of Undersea www.entjournal.com • 687
and Hyperbaric Medicine rather than in the Department of OHNS in order to minimize the amount of time between the evaluations and HBOT. This posed a particular challenge when we tried to evaluate a lack of improvement in the 10 patients who were undergoing HBOT for the treatment of sudden hearing loss. Their hearing might have been worsened (1) by the progression of th eir pre-existing sudden hearing loss, (2) as a complication of their ongoing HBOT, or (3) a combination of the two.
Based on our findings, we conclude that prophylaxis against barotrauma should undertaken for patients who present with pathologic otoscopic findings immediately following th e first session of HBOT, even if those findings are thought to be minor or temporary. The choice of a specific type of prophylaxis and the resulting outcomes are subjects that can be investigated in future prosp ective studies.
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